A nurse is caring for a 45-year-old client who received a kidney transplant 6 months ago and is being seen in the outpatient clinic for routine follow-up. The client's current medications include tacrolimus, mycophenolate, and prednisone. Recent laboratory results show a serum creatinine of 1.2 mg/dL (baseline 1.0 mg/dL) and BUN of 25 mg/dL. The client reports feeling well but mentions occasionally forgetting to take the evening dose of tacrolimus. Which nursing intervention is most important to prevent transplant rejection?

Medication adherence is the most critical factor in preventing transplant rejection, as even brief interruptions in immunosuppressive therapy can trigger acute rejection. Other interventions are important but do not directly prevent rejection like ensuring strict adherence.

Understanding the Clinical Picture

This client is at a critical juncture. Although they report feeling well, the subtle rise in serum creatinine from a baseline of 1.0 mg/dL to 1.2 mg/dL and a BUN of 25 mg/dL are early and concerning signs of possible graft dysfunction. In the context of a kidney transplant, the most immediate threat signaled by the client's history is the occasional missed evening dose of tacrolimus. Tacrolimus is a calcineurin inhibitor and a cornerstone of maintenance immunosuppression. Its primary role is to inhibit T-cell activation, which is the central driver of cellular rejection ^[2].

Why Non-Adherence is the Priority

The immune system's ability to recognize and attack the donated organ is a persistent and powerful process. The mechanism of graft rejection hinges on MHC (major histocompatibility complex) mismatch and subsequent T-cell allorecognition ^[2]. Even brief lapses in immunosuppression can allow a pool of alloreactive T-cells to become activated, proliferate, and mount an attack on the kidney tubules and interstitium. This process, known as acute cellular rejection, can be clinically silent in its earliest stages, with a rise in serum creatinine often being the first and only indicator. The client's missed doses directly compromise the steady-state drug levels needed to continuously suppress this T-cell response, making non-adherence the most modifiable and urgent risk factor for rejection at this moment.

The Interplay of Rejection and Metabolic Factors

While the immediate concern is medication adherence, it is important to understand the broader context of long-term graft survival. The client’s regimen includes tacrolimus and prednisone, both of which contribute to metabolic dysregulation, including hypertension, dyslipidemia, and post-transplant diabetes mellitus ^[1]. These metabolic complications are not just separate issues; they have a bidirectional and deleterious relationship with antibody-mediated rejection (ABMR). Metabolic syndrome can create a pro-inflammatory state that exacerbates endothelial injury, potentially making the graft more susceptible to antibody-mediated damage ^[1]. Therefore, while addressing the immediate crisis of non-adherence to prevent acute cellular rejection, the nurse also recognizes that this same intervention is crucial for mitigating the long-term, intertwined risks of ABMR and metabolic decline.

Analyzing the Incorrect Options

- Option 1 (Monitor for signs of infection): While immunosuppression increases infection risk, the client has no signs or symptoms of infection. The immediate threat signaled by the rising creatinine and history of missed doses is rejection, not a new infection. Strict isolation is not indicated in an asymptomatic outpatient.
- Option 2 (Encourage increased fluid intake): Adequate hydration is supportive for kidney function, but it does not address the underlying pathophysiology of immune-mediated graft injury. It is a secondary intervention that cannot compensate for inadequate immunosuppression.
- Option 3 (Assess for signs of acute rejection): This is a crucial nursing action, but it is an assessment, not the most important intervention to prevent rejection. The question asks for the intervention to prevent rejection, which must target the root cause: the lapse in the immunosuppressive regimen. The subtle creatinine rise is already an early sign, and the priority is to stop the process from progressing further by restoring adherence.

The most critical action to prevent a full-blown rejection episode is to identify the cause of non-adherence and re-establish a strict, consistent schedule for the immunosuppressive medications, particularly the tacrolimus, which is vital for suppressing the T-cell allorecognition that initiates graft destruction ^[2].